The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 933-943

  Papp, Zsuzsanna ^a   Babiuk, Lorne A ^a   Baca Estrada, Maria E ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adenovirus specific immunity; Mucosal; Recombinant adenovirus

Indexed keywords

VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; INTRAGASTRIC DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CATTLE; FEMALE; GENETIC VECTORS; HALF-LIFE; HERPES SIMPLEX; HERPESVIRUS 1, BOVINE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION, PASSIVE; MALE; RATS; RECOMBINATION, GENETIC; SIGMODONTINAE; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0033605093     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00279-5     Document Type: Article

References (28)

1. Rosenthal KL, Copeland KFT, Gallichan WS. Recombinant adenoviruses as vectors for mucosal immunity. In: Kiyono H, Ogra PL, McGhee JR, editors. Mucosal Vaccines. Academic Press, Inc., San Diego, California, 1996. p. 147.
2. Yang Y., Li Q., Ertl H.C.J., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004.
3. Yang Y., Wilson J.M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155:1995;2564.
4. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407.
5. Kaplan J.M., Armentano D., Sparer T.E., Wynn S.G., Peterson P.A., Wadsworth S.C., Couture K.K., Pennington S.E., St. George J.A., Gooding L.R., Smith A.E. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8:1997;45.
6. Yang Y., Trinchieri G., Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1:1995;890.
7. Xiang Z.Q., Yang Y., Wilson J.M., Ertl H.C.J. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology. 219:1996;220.
8. Schulick A.H., Vassalli G., Dunn P.F., Dong G., Rade J.J., Zamarron C. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. J. Clin. Invest. 99:1997;209.
9. Dong J.Y., Wang D., van Ginkel F.W., Pascual D.W., Frizzell R.A. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7:1996;319.
10. Kozarsky K.F., McKinley D.R., Austin L.L., Raper S.E., Stratford-Perricaudet L.D., Wilson J.M. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable with recombinant adenoviruses. J. Biol. Chem. 269:1994;1.
11. Mittal S.K., McDermott M.R., Johnson D.C., Prevec L., Graham F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28:1993;67.
12. Smith T.A.G., Mehaffery M.G., Kayda D.B., Saunders J.M., Yei S., Trapnell B.C., McLelland A., Kaleko M. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Gen. 5:1993;397.
13. Yei S., Mittereder N., Tang K., O'Sullivan C., Trapnell B.C. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:1994;192.
14. Bout A., Imler J-L., Schultz H., Perricaudet M., Zurcher C., Herbrink P., Valerio D., Pavirani A. In vivo adenovirus-mediated transfer of human CFTR cDNA to Rhesus monkey airway epithelium: efficacy, toxicity and safety. Gene Ther. 1:1994;385.
15. Crystal R.G., Mastrangeli A., Sanders A., Cooke J., King T., Gilbert F., Henschke C., Pascal W., Herena J., Harvey B.G., et al. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis. Hum. Gene Ther. 6:1995;667.
16. Mastrangeli A., Daniel C., Rosenfeld M.A., Stratford-Perricaudet L., Pericaudet M., Pavirani A., Lecocq J.P., Crystal R.G. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91:1993;225.
17. Zabner J., Petersen D.M., Puga A.P., Graham S.M., Couture L.A., Keyes L.D., Lukason M.J., St George J.A., Gregory R.J., Smith A.E., Welsh M.J. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Gen. 6:1994;75.
18. Kundig T.M., Kalberer C.P., Hengartner H., Zinkernagel R.M. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. Vaccine. 11:1993;1154.
19. Johnson M.P., Meitin C.A., Bender B.S., Small P.A. Jr. Recombinant vaccinia immunization in the presence of passively administered antibody. Vaccine. 11:1993;665.
20. Andrew M.E. Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice. Immunol. Cell Biol. 67:1989;339.
21. Papp Z., Middleton D.M., Mittal S.K., Babiuk L.A., Baca-Estrada M.E. Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection. J. Gen. Virol. 78:1997;2933.
22. Mittal S.K., Papp Z., Tikoo S.K., Baca-Estrada M.E., Yoo D., Benko M., Babiuk L.A. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology. 222:1996;299.
23. Papp Z, Babiuk LA, Baca-Estrada ME. Induction of immunity in the respiratory tract and protection from bovine herpesvirus type 1 infection by different routes of immunization with recombinant adenovirus. Viral Immunol. (in press).
24. Baca-Estrada M.E., Liang X., Babiuk L.A., Yoo D. Induction of mucosal immunity in cotton rats to hemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus. Immunology. 86:1995;134.
25. Misra V., Blumenthal R.M., Babiuk L.A. Proteins specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J. Virol. 40:1981;1046.
26. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, editors. Methods in Molecular Biology. The Humana Press, Clifton, NJ, 1991. Vol. 7: Gene Transfer and Expression Protocols.
27. van Drunen Littel-van den Hurk S., van den Hurk J.V., Gilchrist J.E., Misra V., Babiuk L.A. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology. 135:1984;466.
28. Setoguchi Y., Jaffe H.A., Chu C-S., Crystal R.G. Intraperitoneal in vivo gene therapy to deliver alfa1-antitrypsin to the systemic circulation. Am. J. Respir. Cell. Mol. Biol. 10:1994;369.